Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):513-7. doi: 10.1177/039463201202500222.
Guillain-Barré syndrome (GBS) is an inflammatory polyneuropathy characterized by acute onset, rapid progression, symmetric muscular weakness, pain, and paresthesias. The incidence of GBS in the pediatric age group is 0.8 cases per 100,000; 50%-70% of the cases are preceded by respiratory or gastrointestinal infectious episodes or vaccination. The etiopathogenesis of GBS has been hypothesized to involve a direct immune-mediated mechanism against the peripheral nerves. A series of 20 patients managed in the Department of Pediatrics of the University of Catania between 2003 and 2011 and evaluated according to epidemiologic, clinical, and therapeutic features is reported.
格林-巴利综合征(GBS)是一种炎症性多神经病,其特征为急性发作、快速进展、对称性肌无力、疼痛和感觉异常。儿科年龄组中 GBS 的发病率为每 10 万人 0.8 例;50%-70%的病例在呼吸道或胃肠道感染发作或疫苗接种之前发生。GBS 的发病机制假说涉及针对周围神经的直接免疫介导机制。本文报告了 2003 年至 2011 年期间在卡塔尼亚大学儿科接受治疗并根据流行病学、临床和治疗特征进行评估的 20 例患者系列。